The Tumor Microenvironment and Metastasis (TMM) Program is the newest Program at the IU Simon Cancer Center (IUSCC);it arose from our strategic plan and from existing collaborations in a working group originally based in the HMI Program, where interactive investigators looked at solid tumors and metastatic processes. The research goals of TMM are to: 1) advance our basic understanding of the role of cancer cell stromal interactions in cancer initiation, progression and metastasis, 2) evaluate the functions of the metastatic niche, and 3) translate discoveries of the pathobiology of solid tumors, the tumor microenvironment, and the metastatic niche into new cancer targets and novel therapies. The ultimate programmatic goal of TMM is to translate discoveries of the tumor microenvironment's pathophysiology into new cancer targets and appropriately targeted therapies for treating metastatic cancers. Two central themes encompass these goals: 1) Cancer cell-stroma interactions and 2) The metastatic niche. Despite its relatively recent establishment in late 2009, TMM is highly productive and collaborative in its basic and translational approaches to understanding the pathobiology of solid tumors, cancer cell-stroma interactions, the tumor microenvironment, and the metastatic niche. TMM has 25 full and 9 associate members from over 14 departments/divisions on the campuses of Indiana University School of Medicine, lU-Bloomington, and Notre Dame, including: Endocrinology, Dermatology, Biochemistry and Molecular Biology, Division of Hem/Onc (Adult and Peds), Pathology and Laboratory Medicine, Radiology, Anatomy and Cell Biology, Neonatal-Perinatal Medicine, Cellular and Integrative Physiology, Clinical Pharmacology, Medical and Molecular Genetics, OB/GYN, and Chemistry/Biochemistry (Notre Dame). Over this funding period, TMM members have published a total of 453 papers, of which 31.2% represent intra-programmatic collaborations, 35.7% represent interprogrammatic collaborations, and 24.7% represent inter-institutional collaborations. The Program has a total of $8.5M in current peer reviewed funding, with $4.3M from the NCI, $$2.6M from other NIH branches, $1.2M from the Department of Defense, $180K from the ACS, and $250K in other peer-reviewed funding.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA082709-15
Application #
8791193
Study Section
Subcommittee G - Education (NCI)
Project Start
1999-09-22
Project End
2019-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
15
Fiscal Year
2014
Total Cost
$96,981
Indirect Cost
$37,936
Name
Indiana University-Purdue University at Indianapolis
Department
Type
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Huang, Xinxin; Guo, Bin; Liu, Sheng et al. (2018) Neutralizing negative epigenetic regulation by HDAC5 enhances human haematopoietic stem cell homing and engraftment. Nat Commun 9:2741
Serratore, Nina D; Baker, Kortany M; Macadlo, Lauren A et al. (2018) A Novel Sterol-Signaling Pathway Governs Azole Antifungal Drug Resistance and Hypoxic Gene Repression in Saccharomyces cerevisiae. Genetics 208:1037-1055
Hoggatt, Jonathan; Singh, Pratibha; Tate, Tiffany A et al. (2018) Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell. Cell 172:191-204.e10
Filley, Anna; Henriquez, Mario; Bhowmik, Tanmoy et al. (2018) Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas. J Neurooncol 137:469-479
Sishtla, Kamakshi; Pitt, Natalie; Shadmand, Mehdi et al. (2018) Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14. Sci Rep 8:16152
Koh, Byunghee; Abdul Qayum, Amina; Srivastava, Rajneesh et al. (2018) A conserved enhancer regulates Il9 expression in multiple lineages. Nat Commun 9:4803
Reese, Michael J; Knapp, Deborah W; Anderson, Kimberly M et al. (2018) In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs. PLoS One 13:e0203517
Singh, Pratibha; Fukuda, Seiji; Liu, Liqiong et al. (2018) Survivin Is Required for Mouse and Human Bone Marrow Mesenchymal Stromal Cell Function. Stem Cells 36:123-129
Olivos 3rd, David J; Perrien, Daniel S; Hooker, Adam et al. (2018) The proto-oncogene function of Mdm2 in bone. J Cell Biochem 119:8830-8840
Shiue, Kevin; Cerra-Franco, Alberto; Shapiro, Ronald et al. (2018) Histology, Tumor Volume, and Radiation Dose Predict Outcomes in NSCLC Patients After Stereotactic Ablative Radiotherapy. J Thorac Oncol 13:1549-1559

Showing the most recent 10 out of 256 publications